Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Neuropharmacology

• Publication date

  1987-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0028-3908(87)90090-6PMID 2444900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The comparative pharmacology of flupenthixol and some reference neuroleptics.

  2009cited by this paper
• Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats

  2004cited by this paper
• Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat.

  1986cited by this paper
• Striato-nigral dynorphin and substance P pathways in the rat

  1986cited by this paper
• Striato-nigral dynorphin and substance P pathways in the rat

  1986cited by this paper
• Receptor-binding profiles of neuroleptics.

  1985cited by this paper
• A general procedure for analysis of proenkephalin B derived opioid peptides.

  1985cited by this paper
• Endopeptidase in human cerebrospinal fluid which cleaves proenkephalin B opioid peptides at consecutive basic amino acids.

  1985cited by this paper
• Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.

  1985cited by this paper
• Comparison of the substance P- and dynorphin-containing projections to the substantia nigra: a radioimmunocytochemical and biochemical study.

  1985cited by this paper
• Analysis of opioid and non-opioid end products of pro-dynorphin in the substantia nigra of the rat.

  1985cited by this paper
• Dynorphin peptides in human substantia nigra.

  1985cited by this paper
• Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction.

  1985cited by this paper
• The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain.

  1985cited by this paper
• Functional classification of different dopamine receptors.

  1985cited by this paper
• A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra

  1984cited by this paper
• Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.

  1984cited by this paper
• Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.

  1984cited by this paper
• Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P.

  1984cited by this paper
• Effect of intranigral injections of dynorphin, dynorphin fragments and alpha-neoendorphin on rotational behaviour in the rat.

  1984cited by this paper
• Evidence that striatal efferents relate to different dopamine receptors.

  1984cited by this paper
• Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activation.

  1984cited by this paper
• Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.

  1984cited by this paper
• An ion exchange chromatography and radioimmunoassay procedure for measuring opioid peptides and substance P.

  1983cited by this paper
• Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline.

  1983cited by this paper
• SCH 23390 - the first selective dopamine D-1 antagonist.

  1983cited by this paper
• Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats.

  1983cited by this paper
• Induction of oral dyskinesias in naive rats by D1 stimulation.

  1983cited by this paper
• SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

  1983cited by this paper
• PHARMACOLOGICAL EVIDENCE FOR THE SUBCLASSIFICATION OF CENTRAL DOPAMINE RECEPTORS IN THE RAT

  1982cited by this paper
• Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization.

  1982cited by this paper
• Dynorphin-immunoreactive neurons in the central nervous system of the rat.

  1982cited by this paper
• Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor

  1982cited by this paper
• Parallel distribution of immunoreactive α-neo-endorphin and dynorphin in rat and human tissue

  1982cited by this paper
• Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway.

  1982cited by this paper
• Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.

  1981cited by this paper
• Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor

  1981cited by this paper
• Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide.

  1981cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Neurotransmitters contained in the efferents of the striatum.

  1980cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• The central effects of a novel dopamine agonist.

  1978cited by this paper
• Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs.

  1978cited by this paper
• On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.

  1977cited by this paper
• Presence of substance P and GABA in separate striatonigral neurons.

  1977cited by this paper
• Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain.

  1977cited by this paper
• Projections of substance P containing neurons from neostriatum to substantia nigra.

  1977cited by this paper

• Food Intake and Reward Mechanisms in Patients with Schizophrenia: Implications for Metabolic Disturbances and Treatment with Second-Generation Antipsychotic Agents

  2006cites this paper
• Reduced ethanol response in the alcohol‐preferring RHA rats and neuropeptide mRNAs in relevant structures

  2006cites this paper
• Cocaine effects on striatal dynorphin and CART neuropeptides : Association to mood disorder

  2003cites this paper
• Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by "binge" pattern cocaine administration.

  2001cites this paper
• A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides.

  1999cites this paper
• The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans.

  1999cites this paper
• Neuroanatomical Bases of the Reinforcing Stimulus Effects of Cocaine

  1998cites this paper
• Immunohistochemical localization of DARPP32 in striatal projection neurons and striatal interneurons in pigeons.

  1998cites this paper
• Dopamine Receptor Modulation of Gene Expression in the Brain

  1997cites this paper
• Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus.

  1997cites this paper
• Dopaminergic and cholinergic interaction in cataleptic responses in mice.

  1997cites this paper
• Opiate modulation of dynorphin conversion in primary cultures of rat cerebral cortex.

  1997cites this paper
• Levels of dynorphin peptides in the central nervous system and pituitary gland of the spontaneously hypertensive rat.

  1997cites this paper
• Met-enkephalin inhibits 5-hydroxytryptamine release from the rat ventral spinal cord via delta opioid receptors.

  1996cites this paper
• Guinea Pig Preprodynorphin mRNA: Primary Structure and Regional Quantitation in the Brain

  1996cites this paper
• Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement.

  1996cites this paper
• Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.

  1996cites this paper
• Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.

  1995cites this paper
• Dynorphin‐immunoreactive neurons in the rat nucleus accumbens: Ultrastructure and synaptic input from terminals containing substance P and/or dynorphin

  1995cites this paper
• The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in sprague-dawley rats

  1995cites this paper
• Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement.

  1995cites this paper
• Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal.

  1995cites this paper
• Dopaminergic terminals form synaptic contacts with enkephalinergic striatal neurons in pigeons: an electron microscopic study.

  1994cites this paper
• Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems.

  1994cites this paper
• Neostriatal modulation of motor cortex excitability.

  1994cites this paper
• Proteinergic profiles in cerebrospinal fluid from alcoholic subjects.

  1994cites this paper
• The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.

  1994cites this paper
• The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.

  1994cites this paper
• Cerebrospinal fluid dynorphin-converting enzyme activity is increased by voluntary exercise in the spontaneously hypertensive rat.

  1993cites this paper
• 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen.

  1993cites this paper
• Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.

  1993cites this paper
• Prodynorphin Biosynthesis and Posttranslational Processing

  1993cites this paper
• CSF Opioids in Pathophysiology

  1993cites this paper
• Endogenous opioids in opiate addiction, influence of genotype and phenotype

  1993cites this paper
• Cocaine: evidence for NMDA- and opioid-mediated antinociception in the tail-flick test.

  1993cites this paper
• Ultrastructural double-labeling demonstrates synaptic contacts between dopaminergic terminals and substance P-containing striatal neurons in pigeons.

  1992cites this paper
• Choline acetyltransferase- and substance P-like immunoreactive elements in fetal striatal grafts in the rat: a correlated light and electron microscopic study.

  1992cites this paper
• N-methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum.

  1992cites this paper
• Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons.

  1991cites this paper
• Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems.

  1991cites this paper
• Role of N-methyl-D-aspartate (NMDA) receptors in the response of extrapyramidal neurotensin and dynorphin A systems to cocaine and GBR 12909.

  1991cites this paper
• Striatonigral projection neurons: A retrograde labeling study of the percentages that contain substance P or enkephalin in pigeons

  1991cites this paper
• Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.

  1991cites this paper
• N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems.

  1991cites this paper
• Striatonigral Projection Neurons: ARetrograde hbeling Study of the orEnkephalininPigeons

  1991cites this paper
• Extensive co‐occurrence of substance P and dynorphin in striatal projection neurons: An evolutionarily conserved feature of basal ganglia organization

  1990cites this paper
• Two different types of dynorphin-A-immunoreactive terminals in rat substantia nigra

  1990cites this paper
• Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization ev

  1990cites this paper
• Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson's disease.

  1990cites this paper
• The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings.

  1990cites this paper
• Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.

  1989cites this paper
• Peptide-dopamine interactions in the central nervous system: implications for neuropsychiatric disorders

  1989cites this paper
• Neuropeptide-processing, -converting, and -inactivating enzymes in human cerebrospinal fluid.

  1988cites this paper
• Cellular and molecular mechanisms of drug dependence.

  1988cites this paper
• Neurokinin Regulation of Midbrain Raphe Neurons: A Behavioral and Anatomical Study

  1988cites this paper
• Characterization of methamphetamine effects on the striatal-nigral dynorphin system.

  1988cites this paper